Motus GI Holdings, Inc. (NASDAQ:MOTS) Expected to Earn Q3 2022 Earnings of ($0.12) Per Share

Motus GI Holdings, Inc. (NASDAQ:MOTSGet Rating) – Oppenheimer issued their Q3 2022 earnings per share (EPS) estimates for Motus GI in a research note issued to investors on Monday, April 25th. Oppenheimer analyst S. Lichtman expects that the company will earn ($0.12) per share for the quarter. Oppenheimer also issued estimates for Motus GI’s FY2022 earnings at ($0.47) EPS and FY2023 earnings at ($0.36) EPS.

Motus GI (NASDAQ:MOTSGet Rating) last posted its earnings results on Tuesday, March 29th. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.01. Motus GI had a negative net margin of 4,867.77% and a negative return on equity of 83.71%. During the same period in the previous year, the business posted ($0.12) earnings per share.

Several other research analysts have also recently commented on the stock. Colliers Securities restated a “buy” rating on shares of Motus GI in a research report on Tuesday, March 22nd. Alliance Global Partners dropped their price objective on shares of Motus GI from $1.75 to $1.40 in a research note on Wednesday, January 26th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $1.48.

NASDAQ MOTS opened at $0.26 on Thursday. Motus GI has a 52 week low of $0.26 and a 52 week high of $1.62. The company has a current ratio of 8.26, a quick ratio of 8.09 and a debt-to-equity ratio of 1.18. The stock has a market cap of $14.53 million, a price-to-earnings ratio of -0.48 and a beta of 2.40. The company has a 50-day moving average price of $0.34 and a two-hundred day moving average price of $0.45.

Several institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC increased its position in shares of Motus GI by 654.5% during the 4th quarter. Virtu Financial LLC now owns 346,639 shares of the company’s stock worth $162,000 after purchasing an additional 300,696 shares in the last quarter. Citadel Advisors LLC increased its position in shares of Motus GI by 541.2% during the 4th quarter. Citadel Advisors LLC now owns 178,982 shares of the company’s stock worth $84,000 after purchasing an additional 151,068 shares in the last quarter. LPL Financial LLC acquired a new stake in shares of Motus GI during the 4th quarter worth about $25,000. Millennium Management LLC increased its position in shares of Motus GI by 20.4% during the 3rd quarter. Millennium Management LLC now owns 118,652 shares of the company’s stock worth $82,000 after purchasing an additional 20,110 shares in the last quarter. Finally, BlackRock Inc. increased its position in shares of Motus GI by 13.5% during the 3rd quarter. BlackRock Inc. now owns 202,808 shares of the company’s stock worth $139,000 after purchasing an additional 24,100 shares in the last quarter. Institutional investors and hedge funds own 13.36% of the company’s stock.

About Motus GI (Get Rating)

Motus GI Holdings, Inc, a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

Featured Articles

Earnings History and Estimates for Motus GI (NASDAQ:MOTS)

Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.